- 全部删除
您的购物车当前为空
Roblitinib (FGF-401) 是一种口服有效的,高选择性的FGFR4抑制剂(IC50:1.9 nM),具有抗癌作用。

Roblitinib (FGF-401) 是一种口服有效的,高选择性的FGFR4抑制剂(IC50:1.9 nM),具有抗癌作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 393 | In stock | |
| 5 mg | ¥ 828 | In stock | |
| 10 mg | ¥ 1,360 | In stock | |
| 25 mg | ¥ 2,530 | In stock | |
| 50 mg | ¥ 3,980 | In stock | |
| 100 mg | ¥ 5,670 | In stock | |
| 200 mg | ¥ 7,680 | In stock |
Roblitinib 相关产品
| 产品描述 | Roblitinib (FGF-401) is an inhibitor of human fibroblast growth factor receptor 4 (FGFR4), with potential antineoplastic activity. Upon administration, Roblitinib binds to and inhibits the activity of FGFR4, which leads to an inhibition of tumor cell proliferation in FGFR4-overexpressing cells. Roblitinib is a receptor tyrosine kinase upregulated in certain tumor cells and involved in tumor cell proliferation, differentiation, angiogenesis, and survival. |
| 靶点活性 | FGFR3:>10 μM, FGFR1:>10 μM, FGFR4:1.1 nM, FGFR2:>10 μM |
| 体内活性 | FGF-401是一种针对固体肿瘤治疗而开发的FGFR4抑制剂。目前,FGF-401正处于I/II期临床研究中,用于治疗表达FGFR4和KLB阳性的固体肿瘤和肝细胞性癌。 |
| 别名 | FGF-401 |
| 分子量 | 506.56 |
| 分子式 | C25H30N8O4 |
| CAS No. | 1708971-55-4 |
| Smiles | COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc23)ncc1C#N |
| 密度 | 1.39 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| 溶解度信息 | Ethanol: 0.83 mg/mL (1.64 mM), Sonication is recommended. DMSO: 2 mg/mL (3.95 mM), Sonication is recommended. | ||||||||||
溶液配制表 | |||||||||||
Ethanol/DMSO
| |||||||||||
评论内容